Healthy Aging and the Gut Microbiome in People With and Without HIV - Scorecard - MDSpire

Healthy Aging and the Gut Microbiome in People With and Without HIV

  • By

  • Brandilyn A Peters

  • Xiaonan Xue

  • David B Hanna

  • Yi Wang

  • Zheng Wang

  • Anjali Sharma

  • Michelle Floris-Moore

  • Deborah Konkle-Parker

  • Maria L Alcaide

  • Anandi N Sheth

  • Elizabeth F Topper

  • Kathleen M Weber

  • Phyllis C Tien

  • Daniel Merenstein

  • Elizabeth Vásquez

  • Yue Chen

  • Matthew J Mimiaga

  • Valentina Stosor

  • Todd T Brown

  • Kristine M Erlandson

  • Stephanie M Dillon

  • Noha S Elsayed

  • Mykhaylo Usyk

  • Christopher C Sollecito

  • Robert C Kaplan

  • Robert D Burk

  • Qibin Qi

  • January 22, 2025

  • 0 min

Share

Clinical Scorecard: The Role of Gut Microbiome in Promoting Healthy Aging Among Individuals With and Without HIV

At a Glance

CategoryDetail
ConditionAging-related comorbidities and gut microbiome alterations in people with and without HIV
Key MechanismsGut microbiome diversity and composition changes with age influence immunity, inflammation, and metabolism, impacting healthy aging
Target PopulationAdults with and without HIV infection
Care SettingHIV clinical care and aging research cohorts

Key Highlights

  • Older age is associated with increased gut microbiome diversity and uniqueness, with specific genera (Akkermansia, Streptococcus) increasing and others (Prevotella, Faecalibacterium) decreasing.
  • An aging-related microbiome score based on 18 genera correlates with age independent of demographic, behavioral, and cardiometabolic factors.
  • Certain microbiota, such as Faecalibacterium, are linked to reduced frailty, while others like Streptococcus associate with higher mortality risk (VACS index).

Guideline-Based Recommendations

Diagnosis

  • Use 16S rRNA gene sequencing of stool samples to assess gut microbiome diversity and composition in aging individuals with and without HIV.

Management

  • Consider gut microbiome composition as a factor in managing aging-related comorbidities in people with HIV.
  • Monitor specific gut genera associated with healthy or unhealthy aging to inform interventions.

Monitoring & Follow-up

  • Assess frailty using the Fried frailty phenotype and mortality risk using the Veterans Aging Cohort Study (VACS) index in conjunction with microbiome profiling.

Risks

  • Recognize that altered gut microbiome in people with HIV may contribute to increased aging-related comorbidities and mortality risk.

Patient & Prescribing Data

Women and men with and without HIV infection enrolled in longitudinal cohort studies

Gut microbiome features vary by age and HIV status; microbiome-targeted strategies may support healthy aging but require further research.

Clinical Best Practices

  • Perform sex-stratified analysis when evaluating gut microbiome data due to differing microbiome characteristics.
  • Exclude confounding factors such as pregnancy and transgender status to facilitate clear interpretation of microbiome-aging relationships.
  • Use comprehensive covariate adjustment including demographic, behavioral, and cardiometabolic factors in microbiome-aging studies.
  • Incorporate longitudinal stool sample collection and repeated measures to capture dynamic microbiome changes with aging.

References

Original Source(s)

Related Content